Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F09%3A00201851" target="_blank" >RIV/00179906:_____/09:00201851 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11160/09:00210067 RIV/00216208:11150/09:00208911 RIV/61989592:15110/09:10223890

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin

Original language description

Targeted agents present with a new spectrum of side-effects, including toxicities that negatively impact the risk of atherosclerosis. The aim of the present study was to evaluate the effect of the combination of targeted therapy and chemotherapy on serumhomocysteine and other laboratory parameters of cardiovascular risk in patients with metastatic colorectal carcinoma.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

<a href="/en/project/NR9096" target="_blank" >NR9096: Risc factors of atherosclerosis in cancer patients</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2009

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Anticancer Research

ISSN

0250-7005

e-ISSN

—

Volume of the periodical

29

Issue of the periodical within the volume

11

Country of publishing house

GR - GREECE

Number of pages

8

Pages from-to

—

UT code for WoS article

000273203300068

EID of the result in the Scopus database

—